Article

Fixed drug combination might offer better trough control

Orlando-A carefully designed comparison study has shown that the fixed combination of dorzolamide-timolol (Cosopt, Merck) is at least as effective as its concomitant components and might provide better trough control in some patients, said Stanley J. Berke, MD, FACS.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Tiimes) EyeCon 2025: Sruthi Arepalli, MD, spotlights a deep dive orbital tour of the eye
© 2025 MJH Life Sciences

All rights reserved.